Half of LatAm HCPs interested in f2f rep visits now and 9 out of 10 once pandemic is controlled

Released November 2020

The New landscape for HCPs in Latin America

Changes in Medical Practice & relationships with Pharma Reps 

 

A new report by Fine’s  Latin American Healthcare Panel, contains fresh data collected from our ongoing COVID-19 Tracking Study.

This has become a must-read for any researcher or marketer interested in developing optimized communications with physicians in Latin America.

Download this free report to prepare for the future of pharma-HCP interactions ->

By reading this report you will learn latest news such as:

–  4 out of 10 doctors claim to have introduced new therapies into their practice during pandemic.

–   LatAm HCPs see recovery in number of patients but still show reduced adherence and very low levels of patient controls.

–  Half of LatAm doctors are interested in receiving in-person pharma reps visits now, and 9 out of 10 would like to have them once the pandemic is controlled.

Access here for a free download of the full report  to check the emerging trends and how these vary among different countries and medical specialties.

About this initiative

Since March 2020, Fine Research has been running a series of tracking waves around COVID-19 impact on Healthcare Professionals in Latin America, including over 11.000 interviews in 15 different countries.

Results have been widely published in the press and media in several countries as well as in articles and webinars sponsored by Market Research industry forums such as ESOMAR Foundation, ESOMAR, Research News, EphMRA, Brazilian Association of Research Companies, Brazilian Association of Research professionals, and GreenBook.